Roland Buhl

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Ian Pavord, Stephanie Korn, Peter Howarth et al. · The Lancet · 2012 · 2.2K citations

Life Sciences, Internal Medicine, Pharmacotherapy +14

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

Oliver Pfaar, Claus Bachert, Albrecht Bufe et al. · Allergo Journal International · 2014 · 348 citations

Life Sciences, Immunology, Allergy +13

Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme

Norbert Krug, Jens M. Hohlfeld, Anne‐Marie Kirsten et al. · New England Journal of Medicine · 2015 · 319 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

Sumita Khatri, Wendy C. Moore, Peter G. Gibson et al. · Journal of Allergy and Clinical Immunology · 2018 · 300 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacy of a new once-daily long-acting inhaled  2-agonist indacaterol versus twice-daily formoterol in COPD

Ronald Dahl, Kian Fan Chung, Roland Buhl et al. · Thorax · 2010 · 274 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17